Celgene Investor

Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: United States
Founded Date: 1986-01-01
Employees Number: 10001+
Funding Status: M&A
Number Of Exits: 24
Estimated Revenue: $10B+

Visit Website
drugsafety@celgene.com
http://twitter.com/celgene
Register and Claim Ownership